Bayer AG Stock CBOE EUROPE EQUITIES - EUROPEAN EQUITIES (NL)
Stocks
BAYNd
DE000BAY0017
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
After hours 14:31:13 | |||
| 36.77 EUR | -2.96% |
|
37.14 | +1.02% |
| 09:07am | The Gulf Gives, the Fed Takes |  |
| 08:37am | AlphaValue/Baader Europe Downgrades Bayer to Add, Lifts PT | MT |
| Market Cap | 37.08B 42.55B 34.18B 32.15B 60.14B 4,010B 60.57B 407B 158B 1,976B 160B 156B 6,850B | P/E 2026 * |
16x | P/E 2027 * | 12.1x |
|---|---|---|---|---|---|
| Enterprise Value | 68.77B 78.93B 63.4B 59.63B 112B 7,439B 112B 754B 293B 3,666B 296B 290B 12,707B | EV / Sales 2026 * |
1.51x | EV / Sales 2027 * | 1.4x |
| Free-Float |
100% | Yield 2026 * |
0.59% | Yield 2027 * | 1.96% |
Last Transcript: Bayer AG
| 1 week | +2.34% | ||
| Current month | +1.41% | ||
| 1 month | -2.26% | ||
| 3 months | -6.99% | ||
| 6 months | +4.42% | ||
| Current year | -0.61% |
| 1 week | 35.59 |  | 38.58 |
| 1 month | 32.9 | | 39.46 |
| 3 years | 18.39 | | 53.79 |
| 5 years | 18.39 | | 67.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 59 | 2023-05-31 |
Judith Hartmann
DFI | Director of Finance/CFO | 57 | 2026-05-31 |
Christian Rommel
CTO | Chief Tech/Sci/R&D Officer | 59 | 2021-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
André van Broich
BRD | Director/Board Member | 56 | 2012-03-31 |
| Director/Board Member | 66 | 2022-03-31 | |
Heike Hausfeld
BRD | Director/Board Member | 60 | 2017-03-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.96% | +2.48% | +34.76% | -29.60% | 42.98B | |
| -0.85% | -5.06% | +40.40% | +143.88% | 992B | |
| -2.16% | -3.76% | +52.18% | +39.76% | 564B | |
| -2.04% | -3.64% | +16.76% | +57.15% | 391B | |
| -2.90% | +0.68% | +24.66% | +16.53% | 330B | |
| -2.36% | -3.12% | +24.71% | +12.95% | 280B | |
| -2.45% | -2.88% | +24.29% | +29.93% | 279B | |
| -1.91% | -0.87% | -41.95% | -48.26% | 196B | |
| -1.82% | -5.29% | +15.78% | +46.70% | 184B | |
| -1.96% | -2.32% | +13.84% | +58.21% | 156B | |
| Average | -2.14% | +0.41% | +20.54% | +32.72% | 374.58B | |
| Weighted average by Cap. | -1.89% | -0.49% | +28.17% | +62.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45.54B 52.27B 41.98B 39.49B 73.87B 4,926B 74.39B 499B 194B 2,428B 196B 192B 8,414B | 46.81B 53.72B 43.15B 40.59B 75.93B 5,063B 76.46B 513B 199B 2,495B 202B 197B 8,648B |
| Net income | 2.17B 2.49B 2B 1.88B 3.52B 235B 3.55B 23.82B 9.25B 116B 9.35B 9.15B 401B | 3B 3.44B 2.76B 2.6B 4.86B 324B 4.89B 32.86B 12.76B 160B 12.91B 12.63B 554B |
| Net Debt | 31.7B 36.38B 29.22B 27.48B 51.42B 3,429B 51.78B 348B 135B 1,690B 137B 134B 5,856B | 28.63B 32.85B 26.39B 24.82B 46.43B 3,096B 46.76B 314B 122B 1,526B 123B 121B 5,289B |
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change |
|---|---|---|
| 26-06-18 | 36.77 € | -2.96% |
| 26-06-17 | 37.89 € | +5.37% |
| 26-06-16 | 35.96 € | -0.50% |
| 26-06-15 | 36.14 € | -0.14% |
| 26-06-12 | 36.19 € | +0.72% |
- Stock Market
- Stocks
- BAYN Stock
- BAYNd Stock
Select your edition
All financial news and data tailored to specific country editions
